AntimetabolitesAntimetabolites, AntineoplasticFloxuridineTetrahydrouridineTrabeculectomyInosine MonophosphateFluorouracilPhosphoribosyl PyrophosphateMitomycinMethotrexate6-MercaptopurineLeukemia L1210Folic Acid AntagonistsAntineoplastic AgentsCytarabinePurinesNeoplasmsDrug Screening Assays, AntitumorDrug SynergismDeoxycytidineCell SurvivalEarly Detection of CancerTumor Cells, CulturedDrug Evaluation, PreclinicalCell CycleCell DivisionCell LineProstatic NeoplasmsOvarian NeoplasmsBreast NeoplasmsLung NeoplasmsStomach NeoplasmsColonic NeoplasmsNeoplasm MetastasisNeoplasm InvasivenessPancreatic NeoplasmsKineticsGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesNeoplasm ProteinsUterine Cervical NeoplasmsSurvival AnalysisGenetic Predisposition to DiseaseSurvival RatePrognosisAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmCarcinomaUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellNational Cancer Institute (U.S.)Disease ProgressionRiskReverse Transcriptase Polymerase Chain ReactionFollow-Up StudiesCell Line, TumorColorectal NeoplasmsRetrospective StudiesReceptors, EstrogenGene Expression ProfilingRegistriesXenograft Model Antitumor AssaysTumor Markers, BiologicalProspective StudiesMutationNeoplasm StagingRNA, MessengerSurvivorsReceptor, erbB-2Risk AssessmentUnited States